Cargando…
Sensitive and affordable diagnostic assay for the quantitative detection of anaplastic lymphoma kinase (ALK) alterations in patients with non-small cell lung cancer
Accurate detection of altered anaplastic lymphoma kinase (ALK) expression is critical for the selection of lung cancer patients eligible for ALK-targeted therapies. To overcome intrinsic limitations and discrepancies of currently available companion diagnostics for ALK, we developed a simple, afford...
Autores principales: | Dama, Elisa, Tillhon, Micol, Bertalot, Giovanni, de Santis, Francesca, Troglio, Flavia, Pessina, Simona, Passaro, Antonio, Pece, Salvatore, de Marinis, Filippo, Dell'Orto, Patrizia, Viale, Giuseppe, Spaggiari, Lorenzo, Di Fiore, Pier Paolo, Bianchi, Fabrizio, Barberis, Massimo, Vecchi, Manuela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095066/ https://www.ncbi.nlm.nih.gov/pubmed/27206799 http://dx.doi.org/10.18632/oncotarget.9471 |
Ejemplares similares
-
Identification and clinical validation of a multigene assay that interrogates the biology of cancer stem cells and predicts metastasis in breast cancer: A retrospective consecutive study
por: Pece, Salvatore, et al.
Publicado: (2019) -
Pathobiology of ALK-negative anaplastic large cell lymphoma
por: Pileri, Stefano A., et al.
Publicado: (2011) -
Pre‐clinical validation of a selective anti‐cancer stem cell therapy for Numb‐deficient human breast cancers
por: Tosoni, Daniela, et al.
Publicado: (2017) -
Adjuvant EGFR TKIs in NSCLC harboring EGFR mutations: looking for a consensus way
por: Attili, Ilaria, et al.
Publicado: (2020) -
Immune Response against ALK in Children with ALK-Positive Anaplastic Large Cell Lymphoma
por: Stadler, Serena, et al.
Publicado: (2018)